missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ IL-23A/IL-23 P19 Antibody (risankizumab) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-28777-1mg
This item is not returnable.
View return policy
Description
IL-23A/IL-23 P19 Monoclonal antibody specifically detects IL-23A/IL-23 P19 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifications
| IL-23A/IL-23 P19 | |
| Monoclonal | |
| Unconjugated | |
| Q9NPF7 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| risankizumab | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| IL-23, IL-23A, IL-23-A, IL-23p19, IL23P19P19, interleukin 23 p19 subunit, interleukin 23, alpha subunit p19, interleukin-23 subunit alpha, Interleukin-23 subunit p19, JKA3 induced upon T-cell activation, MGC79388, SGRFIL-23 subunit alpha | |
| IL-23a | |
| 1 mg | |
| Cancer, Cytokine Research, Innate Immunity | |
| 51561 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction